1.
Short-term safety and efficacy of Preserflo™ Microshunt in glaucoma patients: a multicentre retrospective cohort study.
Bhayani Raj, Martínez de la Casa Jose Maria, Figus Michele, Klabe Karsten, Rabiolo Alessandro, Mercieca Karl
Eye (Lond)Mar 20220 citationsCohort Study
The Preserflo Microshunt effectively lowered IOP and medication use in glaucoma patients over one year, showing good safety but modest success for very low target pressures, guiding surgical selection.